Dyspepsia Flashcards
1
Q
H2- receptor antagonist
Common indications
A
- Peptic ulcer disease- for treatment and prevention of gastric and duodenal ulcers and NSAID-associated ulcers, although PPI are more effective and therefore usually preferred
- GORD and dyspepsia- for releif of symptoms. PPIs are the main alternative and are preffered in more severe cases
2
Q
H2- receptor antagonist
MOA
A
- Histamine H2-antagonists reduce gastric acid secretion
- Acid in normally produced by the proton pump of the gastric parietal cells, which secretes H+ into the stomach lumen in exchange for K+
- Proton pump is regulated by histamine which stimulates the parietal cell via secondary messenger system
- However PP can be stimulated in many ways so H2-antagonists only give a partial blockage of secretions
3
Q
H2- receptor antagonist
Important adverse effects
A
- H2 blockers are well tolerate
- Common side effects: Bowel disturbances (Diarrhoea/constipation), headache and dizziness
4
Q
H2- receptor antagonist
Warnings
A
- H2-blockers are excreted by the kidneys so dose reduction is required in renal impairment
- They can disguise the symptoms of gastric cancer
- Notice alarm symptoms- weight loss, swallowing difficulties)
5
Q
Proton Pump Inhibitors (PPIs)
Common indications
A
- Prevention and treatment of peptic ulcer disesase- including NSAID-associated
- Symptomatic relief of GORD + Dyspepsia
- Eradication of H.pylori infection when used with combination antibiotic therapy
6
Q
Proton Pump Inhibitors (PPIs)
MOA
A
- PPIs reduce gastric acid secretion
- They act by irreversibly inhibiting H+/K+/ATPase pump is gastric parietal cells
- An advantage at targeting the final stage of gastric acid production is that they offer almost complete supression is acid production (compared to partial in H2-antagonists)
7
Q
Proton Pump Inhibitors (PPIs)
Important adverse effects
A
- GI disturbances
- Headache
- Increased risk of C.diff infection
- Hypomagnesaemia- this is linked to hypokalaemia and therefore arrhythmias and tetany
8
Q
Proton Pump Inhibitors (PPIs)
Warnings
A
- PPIs like H2-antagonists can mask the symptoms of gastric cancer
- Increased risk of fracture and oesteoporosis particularly in the elderly
9
Q
Proton Pump Inhibitors (PPIs)
Interactions
A
- There is some evidence that PPIs decrease the antiplatelet effect of clopidogrel by decreasing activation by CYP enzymes
- Lansoprazole and pantoprazole have a lower propensity for this interaction